Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Short Interest Update

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totaling 100 shares, a decline of 80.0% from the August 31st total of 500 shares. Based on an average daily trading volume, of 6,200 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 6,200 shares, the days-to-cover ratio is currently 0.0 days.

Ambu A/S Stock Down 4.8%

Shares of OTCMKTS:AMBBY opened at $14.61 on Wednesday. Ambu A/S has a fifty-two week low of $13.02 and a fifty-two week high of $20.24. The firm’s 50 day moving average price is $15.07 and its 200 day moving average price is $15.73. The company has a quick ratio of 1.73, a current ratio of 2.90 and a debt-to-equity ratio of 0.08. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of 76.89 and a beta of 0.88.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings data on Friday, August 22nd. The company reported $0.07 EPS for the quarter. The company had revenue of $229.16 million for the quarter. Ambu A/S had a net margin of 5.93% and a return on equity of 6.11%.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.